U.S. Gas Utilities Stock News

NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Is 10x Genomics (TXG) Fully Valued Following Its Lausanne Cancer Diagnostics Collaboration?

10x Genomics (TXG) stock is in focus after the company announced a multi year research collaboration with Lausanne University Hospital to study cancer diagnostics using its single cell and spatial platforms. See our latest analysis for 10x Genomics. The Lausanne collaboration lands at a moment when 10x Genomics has been in sharp focus, with the share price at US$47.27 and a 30 day share price return of 21.05% feeding into a 90 day share price return of 110.74% and a 1 year total shareholder...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

How Rising Net Interest Income but Lower Earnings May Shape First Merchants’ (FRME) Profitability Trajectory

In July 2026, First Merchants Corporation reported second-quarter and first-half results showing higher net interest income, with US$158.94 million for the quarter and US$310.24 million for the six months, compared with the prior year. Despite this revenue-related improvement, net income and earnings per share from continuing operations fell for both periods, highlighting pressure on overall profitability even as the bank’s core lending engine expanded. We’ll now examine how this mix of...
NasdaqGM:SYM
NasdaqGM:SYMMachinery

August 2026's Top 3 Stocks Estimated To Trade Below Fair Value

Over the last 7 days, the United States market has remained flat, yet it is up 18% over the past year with earnings projected to grow by 16% annually in the coming years. In this environment, identifying stocks that are trading below their fair value can present opportunities for investors looking to capitalize on potential growth while minimizing risk.
NasdaqGS:VCTR
NasdaqGS:VCTRCapital Markets

3 Growth Stocks With High Insider Ownership To Watch Now

Over the last 7 days, the United States market has remained flat, yet it has experienced an impressive 18% rise over the past year, with earnings forecasted to grow by 16% annually. In such a climate, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
OTCPK:TSPH
OTCPK:TSPHTransportation

3 Penny Stocks With Market Caps Larger Than $40M To Watch

The market remained flat over the last week, yet it is up 18% over the past year, with earnings forecast to grow by 16% annually. Investing in penny stocks—often smaller or newer companies—can still open doors to growth opportunities, particularly when these stocks are backed by strong financial health. This article explores several penny stocks that offer compelling opportunities with less risk than one might expect, showcasing above-average balance sheet resilience.
NYSE:OHI
NYSE:OHIHealth Care REITs

Best Dividend Stocks For August 2026

The United States market remained flat over the last week, but it has risen 18% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying strong dividend stocks can be an effective strategy for investors seeking stable income and potential capital appreciation.
NasdaqGM:IESC
NasdaqGM:IESCConstruction

IES Holdings (IESC) Posted Strong Q3 Growth, Is The Upside Already Priced In?

Why the latest IES Holdings earnings matter for investors IES Holdings (IESC) posted third quarter 2026 results on July 31, with sales of $1,242.7 million and net income of $152.97 million. Earnings per share also rose compared with the prior year. For the first nine months of 2026, IES Holdings reported sales of $3,087.94 million and net income of $354.32 million. Basic and diluted earnings per share from continuing operations were higher than the same period in 2025. See our latest analysis...
NYSE:AMN
NYSE:AMNHealthcare

3 US Defensive Stocks Built For Inflation And Rate Uncertainty

With inflation still running above the Fed’s 2% target and rate expectations shifting with every new comment from policymakers, many investors are rethinking how to position their portfolios. Defensive sector stocks can sometimes offer a steadier ride when interest rates and bond yields are in focus, because these companies sell essential goods and services that people tend to keep buying. This article looks at three U.S. defensive stocks that are closely exposed to the latest Federal Reserve...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Beat Expectations, Is The Stock Now Fully Priced?

Newell Brands (NWL) has just paired stronger second quarter earnings with a higher full year sales growth outlook and a new US$800 million asset based revolving credit facility, drawing fresh attention to the stock. See our latest analysis for Newell Brands. The latest earnings beat, higher sales outlook and new US$800 million credit facility appear to have shifted sentiment toward Newell Brands, with a 1-day share price return of 8.95% and a year-to-date share price return of 50.54%...
NYSE:BH.A
NYSE:BH.AHospitality

Is Biglari Holdings (BH.A) Undervalued After Its Recent Rally?

Biglari Holdings stock performance snapshot Biglari Holdings (BH.A) has drawn investor attention after recent share price moves, with the stock last closing at US$1,984.54. Returns show mixed short term performance, with a decline over the past month but gains over the past 3 months. See our latest analysis for Biglari Holdings. For context, Biglari Holdings has seen its share price pull back over the past month, even after a strong 3 month share price return of 28.42% and a 1 year total...
NasdaqGS:PTCT
NasdaqGS:PTCTBiotechs

PTC Therapeutics (PTCT) Is Down 11.5% After Raising 2026 Outlook And Boosting Profitability - Has The Bull Case Changed?

PTC Therapeutics reported second-quarter 2026 revenue of US$360.52 million and net income of US$83.5 million, and raised its full-year 2026 revenue outlook to between US$1.18 billion and US$1.28 billion, while also appointing long-serving human resources executive Hege Sollie-Zetlmayer to its board. An interesting angle is that the company’s strong quarterly profit contrasts with lower year-to-date revenue versus the prior year, raising questions about how its earnings quality and business...
NYSE:BFH
NYSE:BFHConsumer Finance

How Bread Financial’s Q2 2026 Capital Return Moves May Impact Bread Financial Holdings (BFH) Investors

Bread Financial Holdings, Inc. reported second-quarter 2026 results with net interest income of US$1,039 million and net income of US$146 million, while also completing a buyback of 7,343,098 shares for US$551.36 million and declaring a quarterly dividend of US$0.23 per share payable on September 15, 2026. The combination of higher earnings per share, a large completed repurchase that reduced the share count, and continued cash returns through dividends underscores management’s ongoing focus...
NasdaqGS:PI
NasdaqGS:PISemiconductor

3 US Stocks Built For Tariff Driven Supply Chain Shifts

The latest round of Section 301 and Section 338 tariffs is prompting investors to reconsider how exposed portfolios are to complex global supply chains. Higher duties, extra compliance checks and uncertain trade rules can all squeeze margins or re-route production closer to home. That is where a curated US manufacturing and onshoring screener can help focus attention. It filters for larger, financially healthy companies with operations rooted in North America. In this article, you will see...
NYSE:FTI
NYSE:FTIEnergy Services

TechnipFMC (FTI) Reaffirms Guidance As Strong Results Keep Undervalued Narrative Alive

TechnipFMC (FTI) is back in focus after reporting higher second quarter and first half 2026 revenue and net income compared with last year, while also reaffirming full year revenue guidance for its Subsea and Surface Technologies segments. See our latest analysis for TechnipFMC. TechnipFMC’s results and reaffirmed guidance come after a strong run, with the share price delivering a 51.47% year to date share price return and a very large 5 year total shareholder return. This is despite the 7...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

The Bull Case For TriMas (TRS) Could Change Following Upbeat Guidance And Capital Return Push - Learn Why

TriMas Corporation’s recent second-quarter and six-month 2026 results showed slightly higher sales of US$174.58 million and US$342.86 million respectively, alongside lower quarterly net income of US$13.37 million but a very large six‑month net income of US$814.2 million, while continuing its share repurchase program and affirming a US$0.0400 quarterly dividend. Beneath the headline numbers, the combination of improved profitability from continuing operations, a long-running buyback that has...
NYSE:SAH
NYSE:SAHSpecialty Retail

Does Sonic Automotive’s (SAH) Profit Return and Ongoing Buybacks Reveal Its Core Capital Allocation Bet?

Sonic Automotive, Inc. reported past second-quarter 2026 results with revenue of US$3,934.0 million and net income of US$57.4 million, completing another US$6.82 million share buyback tranche and affirming a US$0.41 per-share dividend. The swing from a prior-year quarterly net loss to profit, alongside long-running buybacks totaling about US$1.29 billion, highlights management’s ongoing emphasis on shareholder returns and operational improvement. We’ll now examine how this return to...
NYSE:JXN
NYSE:JXNDiversified Financial

Is Jackson Financial (JXN) Below Fair Value On Its CEO And CFO Transition?

Jackson Financial (JXN) is entering a planned leadership transition that will place longtime finance executive Don W. Cummings in the Chief Executive Officer role and elevate Brian M. Walta to Chief Financial Officer. See our latest analysis for Jackson Financial. Jackson Financial’s leadership reshuffle arrives during a period of strong stock momentum, with a 30 day share price return of 16.98%, year to date share price return of 13.79%, and a 1 year total shareholder return of 50.40%,...
NYSE:TFX
NYSE:TFXMedical Equipment

How FDA Approval of First Freeze Dried Plasma Platform Will Impact Teleflex (TFX) Investors

Teleflex Incorporated recently received U.S. FDA Biologics License Application approval for EZPLAZ Freeze Dried Plasma, the first FDA-licensed freeze dried plasma for adult transfusions when conventional plasma products are unavailable. This approval gives Teleflex its first biologics license for a blood component and introduces a patented flexible bag format that addresses battlefield and prehospital trauma care logistics. We’ll now examine how this first-of-its-kind FDA-approved freeze...
NYSE:BWA
NYSE:BWAAuto Components

BorgWarner (BWA) Could Be 17% Undervalued Following New Hybrid And SUV Wins

BorgWarner (BWA) stock is drawing attention after new program awards for its eTurbo hybrid system and torque on demand transfer case signaled fresh business in advanced hybrid and SUV drivetrains. See our latest analysis for BorgWarner. Alongside the new hybrid and SUV program wins, BorgWarner’s share price has climbed with a 12.28% 90 day share price return and 36.66% year to date share price return, while the 1 year total shareholder return of 72.15% points to strong momentum that has built...
NYSE:RCUS
NYSE:RCUSBiotechs

Arcus Biosciences (RCUS) Expands Kidney Cancer Collaboration, Is The Stock Still Undervalued?

Arcus Biosciences (RCUS) drew fresh investor attention after announcing a clinical collaboration with Summit Therapeutics to test casdatifan plus ivonescimab in metastatic clear cell renal cell carcinoma within its ARC-20 platform. See our latest analysis for Arcus Biosciences. Arcus Biosciences shares trade at US$28.19, with the stock delivering a 21.04% year to date share price return and a very large 207.75% total shareholder return over the past year, suggesting recent news and clinical...
NasdaqGS:CFFN
NasdaqGS:CFFNBanks

What Capitol Federal Financial (CFFN)'s Strong Q3 Results and Completed Buyback Mean For Shareholders

Capitol Federal Financial, Inc. recently reported third-quarter 2026 results, including US$53.48 million in net interest income, US$23.57 million in net income, minimal net charge-offs of US$148,000, completion of a 9,976,478-share buyback totaling US$72.84 million, and reaffirmed a US$0.085 quarterly dividend per share. Together, higher net interest income, growing net income and the completed share repurchase program underscore management’s clear emphasis on capital return and operating...
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

MetroCity Bankshares (MCBS) Earnings Drew Interest, Is The Stock Still Cheap?

MetroCity Bankshares earnings trigger fresh interest MetroCity Bankshares (MCBS) has drawn investor attention after reporting second quarter 2026 results, with net interest income of $44.04 million and net income of $22.13 million, both higher than the prior year period. See our latest analysis for MetroCity Bankshares. MetroCity Bankshares has seen mixed trading around the earnings release, with the share price slipping 4.09% over the past month but still posting a 34.68% year to date share...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Will Stronger Profitability Guidance And Raft AI Deal Change Leonardo DRS' (DRS) Defense Tech Narrative?

Leonardo DRS, Inc. recently reported past second-quarter 2026 results showing sales of US$913 million and net income of US$86 million, reaffirmed its full-year 2026 revenue guidance, declared a US$0.09 per-share dividend, updated progress on its share repurchase program, and agreed to acquire AI mission software firm Raft LLC for US$450 million in cash. Beyond the headline growth in revenues and earnings, the planned Raft acquisition and raised profitability guidance highlight Leonardo DRS’s...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

First Busey (BUSE) Earnings Jumped And Buybacks Ended, Is The Stock Fairly Valued?

Why First Busey’s latest earnings and buyback matter for investors First Busey (BUSE) has drawn fresh attention after second quarter and year to date results showed much higher net income and earnings per share, alongside the completion of a multi year share repurchase program. See our latest analysis for First Busey. At a share price of $30.86, First Busey has delivered a 15.97% 90 day share price return and a 45.10% 1 year total shareholder return, which indicates that recent earnings and...